Company intelligence / Profile preview

Beiley Biofund

Ownership: Private
Employees: ~4
Development stage: Other

Overview

Beiley Biofund is an active venture capital firm founded in 2024, focused on investing in early-stage life sciences and healthcare companies. The fund size is $66 million USD. It provides financial support, technical expertise, and access to networks for biotech entrepreneurs and startups developing innovative therapeutics that address unmet medical needs. The firm aims to foster growth by supporting portfolio companies with both funding and strategic guidance.

Industry: Investors

Partnerships

GFS (industry partner)

Beyond the preview

Go deeper on Beiley Biofund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beiley Biofund.

Explore the full profile